Comparisons of blots stained with anti-thymulin and anti-SPATS2L antibodies indicate that SPATS2L may be a possible candidate for the precursor of thymulin
(Lee told Undark that more research is underway, including one larger study and another with a comparison group.) If we do some certain studies, he said, the FDA may say, youve shown safety and efficacy. The agency, he added, might then allow the peptides to be compounded: Thats all were asking, he said
Bring your most recent bloodwork, a list of medications youre on, and a clear sense of what youre actually trying to accomplish
Doctors are usually far too busy to research and rely on information available to them
GHK-Cu is not a drug, supplement, or food product, and is not for human consumption, veterinary use, or medical applications